TMCnet News
Market Maker Surveillance Report. LGF, ISIS, NYMX, DGIT, CYTX, FSYS, Winning Stocks With Lowest Price Friction For Friday, November 9th 2012Nov 12, 2012 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4060 companies with "abnormal" market making, 2411 companies with positive Friction Factors and 2988 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Lions Gate Entertainment Corp (NYSE:LGF), ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS), Nymox Pharmaceutical Corp (NASDAQ:NYMX), Digital Generation Inc (NASDAQ:DGIT), Cytori Therapeutics Inc (NASDAQ:CYTX), Fuel Systems Solutions Inc (NASDAQ:FSYS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction LGF $2.080 14.25% 2,211,283 37.44% 2,151,141 36.43% 60,142 289 ISIS $1.070 13.99% 2,079,352 51.08% 1,952,829 47.98% 126,523 1,182 NYMX $0.990 13.36% 90,217 62.34% 53,609 37.04% 36,608 370 DGIT $1.520 17.92% 961,613 50.68% 890,097 46.91% 71,516 471 CYTX $0.610 18.94% 375,461 51.89% 347,477 48.02% 27,984 459 FSYS $2.440 17.80% 150,811 50.49% 147,907 49.51% 2,904 12 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent. For example, the chart above shows LGF with a dollar gain Friday of $2.08000 and a Friction Factor of 289 shares. That means that it only took 289 more shares of buying than selling to move LGF higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal. Lions Gate Entertainment Corp (NYSE:LGF) - Lions Gate Entertainment Corp. engages in the production and distribution of motion pictures, television programming, home entertainment, family entertainment, video-on-demand, and digitally delivered content. The company operates through three segments: Motion Pictures, Television Production, and Media Networks. The Motion Pictures segment engages in the development and production of feature films; acquisition of North American and worldwide distribution rights; North American theatrical, home entertainment, and television distribution of feature films produced and acquired; and worldwide licensing of distribution rights to feature films produced and acquired. The Television Production segment involves in the development, production, and worldwide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming. The Media Networks segment includes TV Guide Network, a general entertainment cable network in the United States, including TV Guide Network On Demand; and TV Guide Online, an online navigational tool, as well as provider of television listings, and video and other entertainment content. This segment also provides programming distribution rights to multi-system cable operators and digital broadcast satellite providers; and sells advertisements on its television channel and related online media platforms. It distributes a library of approximately 8,000 motion picture titles and approximately 4,000 television episodes and programs directly to retailers, video rental stores, DVD rental kiosks, and pay and free television channels in the United States, Canada, the United Kingdom, and Ireland, as well as through various digital media platforms; and indirectly to other international markets through subsidiaries and various third parties. Lions Gate Entertainment Corp. was founded in 1986 and is headquartered in Vancouver, British Columbia.. ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS) - Isis Pharmaceuticals, Inc. engages in the discovery and development of a new class of drugs called antisense drugs using antisense technology, a novel drug discovery platform to generate a broad pipeline of first-in-class drugs. It develops antisense drugs focused on treating cardiovascular, metabolic and severe neurodegenerative diseases, and cancer for systemic, local, and inhaled delivery. The company has commercialized antisense drugs and has 22 drugs in development. Isis Pharmaceuticals has strategic alliances with GlaxoSmithKline, Genzyme Corporation, Archemix Corp., Alnylam Pharmaceuticals, Inc., and Xenon Pharmaceuticals Inc. The company was founded in 1989 and is based in Carlsbad, California.. Nymox Pharmaceutical Corp (NASDAQ:NYMX) - Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs and diagnostic devices in Canada, the United States, and Europe. The companys products include AlzheimAlert, a urinary test that aids physicians in the diagnosis of Alzheimers disease; and NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. Its products under development comprise NX-1207, which is in Phase III clinical trials for the treatment of benign prostatic hyperplasia; and NX-1207, which is ready for human clinical trials for the treatment of hepatocellular carcinoma and localized prostate cancer. The companys products in the preclinical stage comprise NXC-4720, an antibacterial agent for the treatment of E. coli O157:H7 bacterial contamination in hamburger meat and other food and drink products, and for the treatment of urinary tract and other bacterial infections in humans; NXB-4221 for the treatment of difficult chronic and persistent urinary tract infections; NXB-5886 for the treatment of streptococcal infection; and NXT-1021 for the treatment of staphylococcal infection. It is also developing therapeutics for Alzheimers disease; drugs for the treatment of Alzheimers disease that target spherons; and therapeutic products for oncological indications, as well as holds various diagnostic markers and technologies, including a patented platform for point-of-care testing. Nymox Pharmaceutical was founded in 1989 and is based in St. Laurent, Canada.. Digital Generation Inc (NASDAQ:DGIT) - DG FastChannel, Inc. provides digital technology services that enable the electronic delivery of advertisements, syndicated programs, and video news releases to traditional broadcasters, online publishers, and other media outlets. It operates three digital networks from its network operation centers, which link approximately 5,000 advertisers, advertising agencies, and content owners with approximately 29,000 television, radio, cable, print, and Web publishing destinations electronically throughout the United States, Canada, and Europe. The company also involves in the electronic and physical distribution of broadcast advertising content, such as video, audio, and print content to broadcasting stations, as well as delivers political advertising during election campaigns and provides response mechanism for candidates and issue groups. In addition, it offers Unicast Advertising Platform, an online advertising campaign management and deployment product that manages the process of deploying online advertising campaigns; delivers digital video broadcast services through its Digital Media Gateway platform; and owns and maintains SourceEcreative, an online database of content and credits of the U.S. television commercials, as well as provides Web-based marketing solutions. The companys ancillary services include storage of client masters or storyboards, editing of materials, tagging content, dubbing, video duplication, and copying of media onto various physical multimedia formats; and media asset management enables automatic archiving of trafficked spots, online search, send-for-review and review-and-approvals, automated digital storyboarding, and streaming previews, as well as online search, sort, retrieve, and hardcopy fulfillment. DG FastChannel, Inc. was founded in 1991 and headquartered in Irving, Texas.. Cytori Therapeutics Inc (NASDAQ:CYTX) - Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. The company develops its product pipeline for the treatments of cardiovascular disease, spinal disc degeneration, gastrointestinal disorders, liver and renal disease, and pelvic health conditions. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzymes, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. It also intends to offer the PureGraft System in the U.S as a medical device that prepares autologous fat grafts for use in aesthetic body contouring. The company also sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. The company also develops Celution System for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease spinal disc degeneration, and pelvic health conditions. Cytori Therapeutics has strategic development and manufacturing joint venture agreement, and other related agreements with Olympus Corporation. The company was founded in 1996 and is headquartered in San Diego, California.. Fuel Systems Solutions Inc (NASDAQ:FSYS) - Fuel Systems Solutions, Inc. engages in the design, manufacturing, and supply of alternative fuel components and systems for use in the transportation, industrial, and power generation industries. Its components and systems control the pressure and flow of gaseous alternative fuels, such as propane and natural gas used in internal combustion engines. The company offers a range of fuel delivery components, including pressure regulators, fuel injectors, flow control valves, and other components to control the pressure, flow, and/or metering of gaseous fuels; electronic controls comprising solid-state components and proprietary software that monitor and optimize fuel pressure and flow for engine requirements; and gaseous fueled internal combustion engines. It also provides systems integration support to integrate the gaseous fuel storage, fuel delivery, and/or electronic control components and sub-systems; auxiliary power systems for truck and diesel locomotives; and natural gas compressors and refueling systems for light and heavy duty refueling applications. In addition, the company designs, manufactures, assembles, and markets ancillary components for systems operation on alternative fuels, as well as offers engineering and systems integration services. Fuel Systems Solutions, Inc. supplies its products and systems primarily to automobile manufacturers, taxi companies, transit and shuttle bus companies, and delivery fleets through a network of distributors and dealers, as well as through a sales force that develops sales with distributors, original equipment manufacturers, and end-users. Fuel Systems Solutions, Inc. was incorporated in 2005 and is based in New York, New York.. About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures. Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected]. |